US Hospitals Cancel Elective Surgeries, Team Up With Medtechs To Find Remote-Monitoring Solutions
You may also be interested in...
As the pandemic unfolds with an uncertain outcome, US securities analysts that cover publicly traded medtech companies are developing mathematical models to estimate the impact of the COVID-19 pandemic on medtech companies.
Medtech Insight is tracking the IVD companies manufacturing tests for SARS-CoV-2, the coronavirus that causes COVID-19.
In a series of tweets on 16 March, former US FDA commissioner Robert Califf urged manufacturers – regardless of industry – to consider shifting their production to aid in making personal protective equipment such as gloves, masks and gowns.